Literature DB >> 8014445

Fulminant hepatitis after flutamide treatment.

S P Dourakis1, A A Alexopoulou, S J Hadziyannis.   

Abstract

Two cases of severe acute hepatitis in patients taking flutamide for metastatic prostatic carcinoma are reported. Jaundice and marked increase in aminotransferases occurred after 6-8 weeks of treatment. Continuation of flutamide administration was associated with the development of hepatic encephalopathy and a marked prolongation of prothrombin time. One of the patients died of acute liver failure and the other survived after prolonged hospitalization. Rechallenge was not performed because of the severity of the clinical picture. Liver histology showed extensive hepatic necrosis. These two cases strongly suggest that flutamide, in addition to its cholestatic side effects, can induce acute hepatitis potentially with a fulminant and lethal course. Journal of Hepatology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014445     DOI: 10.1016/s0168-8278(94)80006-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  5 in total

1.  Toxic hepatitis after sequential administration of flutamide and cyproterone acetate.

Authors:  Spilios Manolakopoulos; Sotirios Bethanis; Anastasios Armonis; Michalis Economou; Alec Avgerinos; Dimitrios Tzourmakliotis
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

Review 2.  Dose adaptation of antineoplastic drugs in patients with liver disease.

Authors:  Lydia Tchambaz; Chantal Schlatter; Max Jakob; Anita Krähenbühl; Peter Wolf; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis.

Authors:  C Cicognani; M Malavolti; A M Morselli-Labate; C Sama; L Barbara
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

Review 4.  [Toxic hepatitis and liver failure under therapy with flutamide].

Authors:  C Lübbert; M Wiese; R Haupt; B R Ruf
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743

5.  Microscopic polyangiitis complicated by the development of prostate cancer and flutamide-induced hepatitis.

Authors:  D Papaioannides; P Korantzopoulos; C Bouropoulos; P Latsi; M Fotinou; D Orphanidou
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.266

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.